A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC
Clinical trial NCT05144529 · TERMINATED
Trial details
- NCT number
- NCT05144529
- Sponsor
- Eziafa Oduah, MD, PhD, MPH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2024-09-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.